Shares of Moderna fell 3.99% to $148.88 at 10:09 EST on Tuesday, following yesterday’s upward trend. The Nasdaq Stock Market is jumping 0.5% to $12,440.00, following yesterday’s upward trend, This seems, as yet, a somewhat positive trend exchanging session today.

Moderna’s last close was $156.93, 19.90% under its 52-week high of $178.50.

News about Moderna today

Take-two, occidental petroleum, Moderna: what to watch when the stock market opens today. According to today’s article on The Wall Street Journal, "-Shares of the vaccine maker Moderna were down 1% premarket. "

Moderna vaccine found safe, effective ahead of key FDA review. According to today’s article on Bloomberg Quint, "Moderna’s vaccine isn’t yet approved in any other countries and hasn’t yet been used on anyone outside of a clinical trial.", "Between Pfizer and Moderna, Operation Warp Speed officials have said 20 million people in the U.S. are expected to get their first shots by year-end."

Moderna vaccine found safe, effective before key FDA review. According to today’s article on Bloomberg Quint, "In addition, there were two cases of serious facial swelling in vaccine recipients that Moderna determined were related to vaccination. ", "The FDA got a much deeper look at Moderna’s clinical-trial data than the numbers previously released to the public by the company. "

Moderna shares up in premarket as FDA calls covid-19 vaccine 'highly effective'. According to today’s article on MarketWatch, "Shares of Moderna Inc. gained 1.5% in premarket trading on Tuesday after the Food and Drug Administration said the company’s COVID-19 vaccine candidate is “highly effective” at preventing infections with the coronavirus. "

Moderna’s Sales

Moderna’s sales growth is 1428.1% for the current quarter and 13065.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 48.6% and positive 565.7% for the next.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.

Moderna’s Stock Top and Bottom Yearly Value

Moderna’s stock is valued at $148.88 at 10:09 EST, way under its 52-week high of $178.50 and way higher than its 52-week low of $17.68.

Moderna’s Moving Average

Moderna’s value is way above its 50-day moving average of $104.71 and way above its 200-day moving average of $77.26.

Previous days news about Moderna

Moderna offers U.S. fail-safe on vaccines if Pfizer falls short. According to Bloomberg Quint on Thu Dec 10, "Moderna’s shot is expected to go before the same panel on Dec. 17th.", "Moderna Inc. could offer a fail-safe option that will allow the U.S. to get enough Covid-19 shots to inoculate most Americans if the government can’t reach an agreement to quickly buy more vaccine from Pfizer Inc., which plans to honor its contracts with other countries."

Moderna says U.S. to buy 100 million additional vaccine doses. According to Bloomberg Quint on Fri Dec 11, "Read More: Moderna Offers U.S. Fail-Safe on Vaccines If Pfizer Falls Short", "As part of Operation Warp Speed, the U.S. initiative to rapidly develop and secure vaccines for Covid-19, the U.S. has the option to buy another 300 million doses from Moderna at a fixed price of $16.50 per shot, the company said. "

LEAVE A REPLY

Please enter your comment!
Please enter your name here